These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1093 related items for PubMed ID: 17642308

  • 21. Yersinia Yop-specific IgA antibodies in Hungarian blood donors.
    Sonnevend A, Czirók E, Pál T.
    Folia Microbiol (Praha); 2005; 50(3):269-72. PubMed ID: 16295667
    [Abstract] [Full Text] [Related]

  • 22. [Yersiniosis in Poland in 2008].
    Napiórkowska A, Sadkowska-Todys M.
    Przegl Epidemiol; 2010; 64(2):213-6. PubMed ID: 20731224
    [Abstract] [Full Text] [Related]

  • 23. [Comparison of 2 methods of hemagglutination tests for antibodies against strains of Yersinia enterocolitica and Yersinia pseudotuberculosis].
    Rutová J.
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jan; 38(1):40-7. PubMed ID: 2646030
    [Abstract] [Full Text] [Related]

  • 24. Comparison of bacteria with and without plasmid-encoded proteins as antigens for measurement of immunoglobulin M, G, and A antibodies to Yersinia enterocolitica by enzyme-linked immunosorbent assay.
    Granfors K, Lahesmaa-Rantala R, Ståhlberg TH, Toivanen A.
    J Clin Microbiol; 1989 Mar; 27(3):583-5. PubMed ID: 2715330
    [Abstract] [Full Text] [Related]

  • 25. [Evaluation of usefulness of a new generation of tests for detection in humans of antibodies for 9,12 antigens of Salmonella. I. Occurrence and level of antibodies detected by DOT-ELISA, latex and passive hemagglutination tests].
    Szych J.
    Med Dosw Mikrobiol; 1993 Mar; 45(4):439-55. PubMed ID: 8189824
    [Abstract] [Full Text] [Related]

  • 26. Yersinia antibodies in inflammatory joint diseases.
    Granfors K, Isomäki H, von Essen R, Maatela J, Kalliomäki JL, Toivanen A.
    Clin Exp Rheumatol; 1983 Mar; 1(3):215-8. PubMed ID: 6335856
    [Abstract] [Full Text] [Related]

  • 27. Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis.
    Ståhlberg TH, Heesemann J, Granfors K, Toivanen A.
    Ann Rheum Dis; 1989 Jul; 48(7):577-81. PubMed ID: 2774698
    [Abstract] [Full Text] [Related]

  • 28. Antibody response in Yersinia pseudotuberculosis III infection: analysis of an outbreak.
    Ståhlberg TH, Tertti R, Wolf-Watz H, Granfors K, Toivanen A.
    J Infect Dis; 1987 Aug; 156(2):388-91. PubMed ID: 3298459
    [No Abstract] [Full Text] [Related]

  • 29. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis.
    Granfors K, Merilahti-Palo R, Luukkainen R, Möttönen T, Lahesmaa R, Probst P, Märker-Hermann E, Toivanen P.
    Arthritis Rheum; 1998 May; 41(5):855-62. PubMed ID: 9588737
    [Abstract] [Full Text] [Related]

  • 30. [Clinico-immunologic characteristics of complicated and uncomplicated yersiniosis].
    Inina LI, Ivanova MM, Akimova TF, Motovilov AA, Malov IV.
    Vestn Akad Med Nauk SSSR; 1989 May; (6):60-4. PubMed ID: 2773563
    [Abstract] [Full Text] [Related]

  • 31. Antibodies to ubiquitin in relation to Yersinia infection status in patients with ankylosing spondylitis.
    Hrycaj P, Łacki JK.
    Clin Rheumatol; 2003 Feb; 22(1):33-6. PubMed ID: 12605315
    [Abstract] [Full Text] [Related]

  • 32. Human antibody response to individual chromosome- and plasmid-encoded antigens of Yersinia enterocolitica 0:3.
    Ståhlberg TH, Granfors K, Toivanen A.
    Contrib Microbiol Immunol; 1987 Feb; 9():290-5. PubMed ID: 3665508
    [No Abstract] [Full Text] [Related]

  • 33. Significance of Yersinia enterocolitica isolates and antibody titers. A prospective study in patients with enteritis and healthy controls under bacteriological, serological, epidemiological and clinical aspects.
    Bitzan M, Knapp W, Mauff G, Pulverer G.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Mar; 254(1):78-88. PubMed ID: 6675345
    [Abstract] [Full Text] [Related]

  • 34. Immunoblot analysis of human IgM, IgG and IgA responses to plasmid-encoded antigens of Yersinia enterocolitica serovar O3.
    Ståhlberg TH, Granfors K, Toivanen A.
    J Med Microbiol; 1987 Sep; 24(2):157-63. PubMed ID: 2443704
    [Abstract] [Full Text] [Related]

  • 35. [Yersiniosis in Poland in 2009].
    Furman S, Napiórkowska A, Sadkowska-Todys M.
    Przegl Epidemiol; 2011 Sep; 65(2):235-8. PubMed ID: 21913466
    [Abstract] [Full Text] [Related]

  • 36. [Role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis. II. Antibodies to Salmonella and Yersinia in sera and synovial fluids].
    Rastawicki W, Jagielski M, Gierczyński R, Garwolińska H, Kwiatkowska B, Filipowicz-Sosnowska A.
    Med Dosw Mikrobiol; 2005 Sep; 57(2):143-51. PubMed ID: 16134386
    [Abstract] [Full Text] [Related]

  • 37. Yersinia-specific antibodies in serum and synovial fluid in patients with Yersinia triggered reactive arthritis.
    Mäki-Ikola O, Lahesmaa R, Heesemann J, Merilahti-Palo R, Saario R, Toivanen A, Granfors K.
    Ann Rheum Dis; 1994 Aug; 53(8):535-9. PubMed ID: 7944640
    [Abstract] [Full Text] [Related]

  • 38. IgA class antibodies against Yersinia enterocolitica O:3 in patients with thyroid disease.
    Leino R, Lahesmaa-Rantala R, Granfors K, Toivanen A.
    Acta Endocrinol (Copenh); 1988 Sep; 119(1):81-4. PubMed ID: 3414323
    [Abstract] [Full Text] [Related]

  • 39. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome.
    Kobayashi S, Ogasawara M, Maeda K, Yu DT.
    J Lab Clin Med; 1985 Mar; 105(3):380-9. PubMed ID: 3871831
    [Abstract] [Full Text] [Related]

  • 40. Combined use of released proteins and lipopolysaccharide in enzyme-linked immunosorbent assay for serologic screening of Yersinia infections.
    Mäki-Ikola O, Heesemann J, Lahesmaa R, Toivanen A, Granfors K.
    J Infect Dis; 1991 Feb; 163(2):409-12. PubMed ID: 1988526
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 55.